Kurebayashi et al. [80] studied the relationship between the growth-promoting effects of estradiol and the growth-inhibitory effects of an anti-estrogen in an ER-positive breast cancer cell line and observed that hypoxia was significantly reduced in both. Here, ESR1 is linked to breast carcinoma.